Mitochondrial Dysfunction and Immune Cell Metabolism in Sepsis.

Area of Science:

• Immunology
• Cellular Biology
• Pathophysiology

Background:

• Sepsis is a critical systemic condition triggered by infection, hemorrhage, or trauma, leading to significant organ injury, mortality, and immune dysfunction.
• Dysregulation of immune cell bioenergetics and metabolic plasticity is increasingly recognized as a key factor in sepsis pathogenesis.
• Understanding these metabolic shifts is crucial for addressing sepsis-related morbidity and mortality.

Purpose of the Study:

• To review the role of mitochondrial biology and cellular metabolism in sepsis.
• To elucidate the metabolic alterations occurring in immune cells during sepsis.
• To identify potential therapeutic strategies targeting immune cell bioenergetics in sepsis.

Main Methods:

• Literature review focusing on cellular bioenergetics and immune cell metabolism in sepsis.
• Analysis of studies detailing mitochondrial function and metabolic pathways in sepsis models.
• Synthesis of current research on therapeutic interventions related to metabolic reprogramming.

Main Results:

• Sepsis significantly impacts immune cell mitochondrial function and metabolic pathways.
• Loss of metabolic plasticity in immune cells contributes to sepsis-induced organ injury and immune suppression.
• Specific metabolic alterations include changes in glucose metabolism, fatty acid oxidation, and mitochondrial respiration.

Conclusions:

• Cellular bioenergetics and metabolic plasticity are critical determinants of sepsis outcomes.
• Targeting mitochondrial function and metabolic pathways in immune cells presents promising therapeutic avenues.
• Further research into metabolic interventions could mitigate sepsis-associated complications and mortality.